Literature DB >> 11292270

Classic conditioning and dysfunctional cognitions in patients with panic disorder and agoraphobia treated with an implantable cardioverter/defibrillator.

F Godemann1, B Ahrens, S Behrens, R Berthold, C Gandor, F Lampe, M Linden.   

Abstract

OBJECTIVE: A model for the development of anxiety disorders (panic disorder with or without agoraphobia) is needed. Patients with an implantable cardioverter/defibrillator (ICD) are exposed to repeated electric shocks. If the theory of anxiety development by aversive classic conditioning processes is valid, these repeated shocks should lead to an increased risk of anxiety disorders. To study this hypothesis, we retrospectively studied 72 patients after implantation of an automatic ICD.
METHODS: Patients were assessed with the semistructured Diagnostic Interview of Psychiatric Disease 1 to 6 years after implantation of an automatic ICD. Panic disorder and/or agoraphobia was diagnosed in patients who fulfilled all DSM-III-R criteria for those conditions.
RESULTS: Anxiety disorder developed in 15.9% of patients after ICD implantation. This was significantly related to the frequency of repeated defibrillation (shocks) to stop malignant ventricular arrhythmias. Dysfunctional cognitions are an additional vulnerability factor.
CONCLUSIONS: The data support both the conditioning hypothesis and the cognitive model of anxiety development. These findings suggest that ICD patients are an appropriate risk population for a prospective study of the development of anxiety disorders.

Entities:  

Mesh:

Year:  2001        PMID: 11292270     DOI: 10.1097/00006842-200103000-00006

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  6 in total

Review 1.  Understanding implantable cardioverter defibrillator shocks and storms: medical and psychosocial considerations for research and clinical care.

Authors:  Samuel E Sears; Jamie B Conti
Journal:  Clin Cardiol       Date:  2003-03       Impact factor: 2.882

2.  Determinants of the quality of life (QoL) in patients with an implantable cardioverter/defibrillator (ICD).

Authors:  F Godemann; C Butter; F Lampe; M Linden; S Werner; S Behrens
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

3.  Tetanizing prepulse: A novel strategy to mitigate implantable cardioverter-defibrillator shock-related pain.

Authors:  David W Hunter; Harikrishna Tandri; Henry Halperin; Leslie Tung; Ronald D Berger
Journal:  Heart Rhythm       Date:  2016-01-06       Impact factor: 6.343

4.  The role of the amygdala in the pathophysiology of panic disorder: evidence from neuroimaging studies.

Authors:  Jieun E Kim; Stephen R Dager; In Kyoon Lyoo
Journal:  Biol Mood Anxiety Disord       Date:  2012-11-20

Review 5.  Psychological effects of implantable cardioverter defibrillator shocks. A review of study methods.

Authors:  Gian Mauro Manzoni; Gianluca Castelnuovo; Angelo Compare; Francesco Pagnini; Vidal Essebag; Riccardo Proietti
Journal:  Front Psychol       Date:  2015-02-04

6.  Avoidance behavior associated with depressive symptoms in patients with implantable cardioverter defibrillators.

Authors:  Kanako Ichikura; Sayaka Kobayashi; Shiho Matsuoka; Tsuyoshi Suzuki; Katsuji Nishimura; Tsuyoshi Shiga; Nobuhisa Hagiwara; Jun Ishigooka; Shin-Ichi Suzuki
Journal:  Int J Clin Health Psychol       Date:  2016-11-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.